Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N.
Thomas KS, et al. Among authors: schmitt j.
Br J Dermatol. 2020 Nov 11. doi: 10.1111/bjd.19673. Online ahead of print.
Br J Dermatol. 2020.
PMID: 33179283